We demonstrate that a 4‐week long delivery of 3.0 mg/kg/day pridopidine prevented weight loss and motor impairments in a delayed onset SOD1 G93A mouse model of ALS. Here, SOD1 is linked to amyotrophic lateral sclerosis.